Scarica l'app Stockscreener
73.08
1.12%
0.81
Dopo l'orario di chiusura:
72.56
-0.52
-0.71%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term - Yahoo Finance
SENS Eversense 365 Integrated With twiist Gains Full Availability - TradingView
The 5 Most Interesting Analyst Questions From DexCom’s Q4 Earnings Call - The Globe and Mail
The Strong Earnings Posted By DexCom (NASDAQ:DXCM) Are A Good Indication Of The Strength Of The Business - simplywall.st
The 5 Most Interesting Analyst Questions From DexCom's Q4 Earnings Call - Finviz
P/E Ratio Insights for DexCom - Benzinga
NEOS Investment Management LLC Boosts Position in DexCom, Inc. $DXCM - Defense World
What Wall Street predicts for DexCom Inc. stock pricePortfolio Gains Summary & Free Real-Time Volume Trigger Notifications - mfd.ru
Dexcom G6 Glucose Monitor Lawsuit Claims Manufacturer’s Device Modifications Resulted in Teen’s Death - AboutLawsuits.com
Dexcom Stock After Volatility: Is This High-Growth Medtech Now Mispriced? - AD HOC NEWS
What DexCom (DXCM)'s Margin Beat And Reaffirmed 2026 Outlook Means For Shareholders - simplywall.st
The DexCom, Inc. (NASDAQ:DXCM) Yearly Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
DexCom Inc. (DXCM) Reports Strong Performance While Maintaining Forward Outlook - Bitget
10 Best Medical Technology Stocks to Invest In - Insider Monkey
DexCom Earnings Call Highlights Margin Rebound, Growth - The Globe and Mail
Is DexCom Inc. in a consolidation phaseJuly 2025 Final Week & Weekly Breakout Watchlists - mfd.ru
DexCom (DXCM) Margin Expansion To 17.9% Reinforces Bullish Earnings Narratives - Sahm
DexCom’s AI Stelo Upgrade Faces Valuation Questions After Share Declines - Sahm
DexCom Expands G7 And Stelo To Deepen CGM Ecosystem Engagement - Yahoo Finance
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth - sharewise.com
DexCom (DXCM) Maintains Buy Rating Despite Lowered Price Target - GuruFocus
Key facts: DexCom reports $2.8B profit; Wells Fargo cuts price target - TradingView
Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday? - Benzinga
Why Is DexCom (DXCM) Stock Rocketing Higher Today - Finviz
Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations - Yahoo Finance
Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes - MedTech Dive
Barclays Updates Rating on DexCom (DXCM) with Slight Price Targe - GuruFocus
DexCom (NASDAQ:DXCM) Stock Price Up 8.4% on Earnings Beat - MarketBeat
Wells Fargo & Company Has Lowered Expectations for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
DXCM Q4 Deep Dive: New Product Launches and International Strategy Drive Outlook - Finviz
DexCom, Inc. (NASDAQ:DXCM) Q4 2025 Earnings Call Transcript - Insider Monkey
DexCom (NASDAQ:DXCM) Price Target Raised to $90.00 - MarketBeat
DexCom, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bernstein Adjusts DexCom Price Target to $83 From $86, Maintains Outperform Rating - marketscreener.com
Baird Adjusts DexCom Price Target to $87 From $82, Maintains Outperform Rating - marketscreener.com
Mizuho Securities Adjusts DexCom Price Target to $90 From $78, Maintains Outperform Rating - marketscreener.com
Wells Fargo Adjusts DexCom Price Target to $85 From $93, Maintains Overweight Rating - marketscreener.com
7 Analysts Have This To Say About DexCom - Benzinga
DexCom (DXCM) Gets a Reaffirmed "Buy" Rating from BTIG | DXCM St - GuruFocus
Stifel reiterates Buy rating on DexCom stock, maintains $85 price target By Investing.com - Investing.com South Africa
DexCom (NASDAQ:DXCM) Exceeds Q4 CY2025 Expectations - The Globe and Mail
Stifel reiterates Buy rating on DexCom stock, maintains $85 price target - Investing.com
DexCom Expands Stelo AI Features As Consumer Glucose Strategy Evolves - Sahm
Decoding DexCom Inc (DXCM): A Strategic SWOT Insight - GuruFocus
DexCom Inc (DXCM) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Dexcom Q4 2025 presentation slides: double-digit growth amid margin expansion - Investing.com South Africa
DexCom Q4 2025 Earnings Call Insights - Intellectia AI
Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results - BioSpace
DexCom (DXCM) Surpasses Q4 2025 Earnings Expectations - GuruFocus
DexCom (DXCM) Q4 2025 Earnings Call Transcript - The Globe and Mail
DexCom (NASDAQ:DXCM) Announces Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Dexcom (DXCM) Reports Strong Q4 Revenue with Promising Future Ou - GuruFocus
DexCom Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Dexcom Q4 2025 beats forecasts, stock dips By Investing.com - Investing.com South Africa
Dexcom Inc (NASDAQ:DXCM) Beats Q4 Profit Estimates Despite Revenue Shortfall - ChartMill
DexCom Reports Better-Than-Expected Q4 Results: Details - Bitget
Earnings call transcript: Dexcom Q4 2025 beats forecasts, stock dips - Investing.com
DEXCOM INC SEC 10-K Report - TradingView
DexCom (DXCM) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
0.97%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):